monodansylthiacadaverine has been researched along with Myelodysplastic Syndromes in 1 studies
*Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrew, G; Craddock, C; Crawley, C; Dillon, R; Freeman, S; Gilleece, M; Hodgkinson, A; Jackson, A; Khan, N; Krishnamurthy, P; Loke, J; Mason, J; McCarthy, N; Peniket, A; Potter, V; Protheroe, R; Salim, R; Siddique, S; Tholouli, E; Wilson, K | 1 |
1 other study(ies) available for monodansylthiacadaverine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS.
Topics: Allografts; Chimerism; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; T-Lymphocytes | 2023 |